PMTR

ANALYST NOTE: PMTR (Perimeter Acquisition Corp. I) Date: 2026-06-13 Subject: Structural Setup & Business Fundamentals Review

1. Structural Readiness

• State: Context-Only.
• Conservative Entry: Not yet defined (requires a confirmed breakout close).
• Aggressive/Pre-Breakout Entry: $10.45 (Current Price).
• *Note:* A close below $10.00 would invalidate the setup, as it would signal a breach of the trust floor and potential liquidation risk.
• Breakout Level: >$10.45 (Requires a sustained close above current levels to confirm structural strength).
• Current Price: $10.45.
• Extension: Minimal (Price is trading at a slight premium to the $10.00 IPO price, but within normal SPAC volatility bands).
• ATR Context: Current ATR is 0.5% (Sub-threshold). This indicates low volatility and a lack of immediate directional conviction. The ATR at breakout is currently undefined as no breakout has occurred.

2. Thesis Layer

• Thesis Classification: Tactical, Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this specific ticker as of 2026-06-13. While the management team has historically expressed interest in defense and national security sectors (see Evidence E8-E12), the company itself is a blank check vehicle with no operating revenue or specific target acquisition announced.
• Judgment Criteria: The investment case must be judged strictly on the quality of the setup structure (price holding above $10.00), the management's ability to consummate a deal before the deadline, and the fundamental value of the trust account relative to the share count. No macroeconomic tailwinds can be assumed to drive the price without a confirmed business combination.

3. Business Fundamentals

• Business Model: Perimeter Acquisition Corp. I is a Cayman Islands exempted company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. As of the latest reporting, it has no operations.
• Industry: Financial Services (SPAC).
• Key Financials & Status (as of March 31, 2026):
• Cash Position: The Company held $503,428 in cash.
• Working Capital: The Company reported a working capital deficit of $152,530.
• Trust Account: The IPO generated gross proceeds of $241,500,000 from the sale of 24,150,000 units at $10.00 per unit (Evidence E5).
• Debt: An unsecured promissory note of $483,000 was issued to Gamma Securities LLC on June 23, 2025, to fund working capital (Evidence E6).
• Operational Status: As of March 31, 2026, the Company had not commenced any operations (Evidence E4).
• Management Focus: Management intends to focus on industries complementing their background, specifically targeting the defense and national security sectors in the U.S. or allied nations (Evidence E8). They cite global defense spending at $2.4 trillion (2023) and expected DOD funding growth of 2.4% CAGR through 2029 as the rationale for their target selection (Evidence E9, E10).

4. Archetype & Conviction

• Archetype: Deep Value Recovery / Special Situation.
• *Fit:* The name fits the "Deep Value" archetype only in the context of the Trust Account floor ($10.00). The current price ($10.45) represents a slight premium to the liquidation value, but the company is fundamentally a shell with a working capital deficit. The "recovery" potential is entirely dependent on the successful execution of a Business Combination.
• Conviction Stack:
• Thesis Strength: Low. No specific target or deal announced. Reliance on management's stated intent to find a defense/tech target.
• Evidence Quality: Moderate. Financials are clear (cash, deficit, trust size), but operational evidence is nil.
• Structural Quality: Weak. The setup is "Forming" with sub-threshold volatility (0.5% ATR). The working capital deficit ($152k) relative to the $483k note creates a liquidity constraint that management must resolve before a deal closes.
• Rerating Potential: High *if* a deal is announced; Zero *if* the deadline passes.
• Valuation Context: The company trades at a slight premium to the IPO price ($10.00). The Trust Account value per share is effectively $10.00 (assuming no significant interest income erosion or fees, though the exact trust balance is not explicitly detailed in the provided evidence beyond the initial proceeds). The current price of $10.45 implies the market is pricing in a non-zero probability of a successful deal.

5. Invalidations, Strengths, and Gaps

• Invalidation Triggers:
• Failure to consummate a Business Combination by May 14, 2027 (Evidence E2).
• Inability to service the $483,000 Working Capital Note or resolve the working capital deficit.
• Strengthening Factors:
• Announcement of a definitive agreement for a Business Combination with a target in the defense/national security sector.
• Extension of the deadline beyond May 14, 2027, via shareholder vote.
• Resolution of the working capital deficit through additional capital injection or conversion of the promissory note.
• Evidence Gaps:
• Target Identification: No specific target company or sector deal has been announced as of 2026-06-13.
• Trust Balance: The exact current balance of the Trust Account (excluding the initial $241.5M) is not provided in the evidence, only the initial proceeds.
• Management Compensation: No details on sponsor promote or management fees are provided in the evidence block.
• Deal Timeline: No specific timeline for the deal announcement is provided, only the hard deadline.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key risks: Working capital deficit of $152,530; No operating revenue or target announced; Hard deadline of May 14, 2027 to consummate a deal; Sub-threshold volatility (0.5% ATR) indicating lack of momentum. Sizing hint: Position size should be minimal, reflecting the binary nature of the SPAC outcome and the lack of confirmed catalyst. Expected path: Management must identify a target and negotiate a deal before May 2027; price likely remains range-bound near $10.00-$10.50 until a definitive announcement is made. Expected horizon: 12 to 24 months (until the May 2027 deadline). Failure mode to watch: A sustained close below $10.00 or a public announcement that the company is extending the deadline due to lack of suitable targets.